Ladenburg Thalmann Financial Services’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $2K | Sell |
1,069
-599
| -36% | -$1.12K | ﹤0.01% | 5043 |
|
2019
Q3 | $4K | Buy |
1,668
+1,164
| +231% | +$2.79K | ﹤0.01% | 4754 |
|
2019
Q2 | $1K | Hold |
504
| – | – | ﹤0.01% | 5081 |
|
2019
Q1 | $2K | Buy |
504
+11
| +2% | +$44 | ﹤0.01% | 4912 |
|
2018
Q4 | $1K | Sell |
493
-600
| -55% | -$1.22K | ﹤0.01% | 5012 |
|
2018
Q3 | $7K | Buy |
1,093
+1,066
| +3,948% | +$6.83K | ﹤0.01% | 4435 |
|
2018
Q2 | $1K | Hold |
27
| – | – | ﹤0.01% | 4963 |
|
2018
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 4963 |
|
2017
Q4 | $1K | Hold |
27
| – | – | ﹤0.01% | 4880 |
|
2017
Q3 | $1K | Hold |
27
| – | – | ﹤0.01% | 4773 |
|
2017
Q2 | $1K | Sell |
27
-58
| -68% | -$2.15K | ﹤0.01% | 4710 |
|
2017
Q1 | $5K | Buy |
85
+40
| +89% | +$2.35K | ﹤0.01% | 4290 |
|
2016
Q4 | $2K | Sell |
45
-25
| -36% | -$1.11K | ﹤0.01% | 4513 |
|
2016
Q3 | $4K | Buy |
70
+13
| +23% | +$743 | ﹤0.01% | 4249 |
|
2016
Q2 | $4K | Sell |
57
-31
| -35% | -$2.18K | ﹤0.01% | 4202 |
|
2016
Q1 | $5K | Sell |
88
-16
| -15% | -$909 | ﹤0.01% | 4055 |
|
2015
Q4 | $24K | Sell |
104
-20
| -16% | -$4.62K | ﹤0.01% | 3081 |
|
2015
Q3 | $20K | Buy |
124
+38
| +44% | +$6.13K | ﹤0.01% | 3097 |
|
2015
Q2 | $33K | Buy |
86
+27
| +46% | +$10.4K | ﹤0.01% | 2871 |
|
2015
Q1 | $24K | Sell |
59
-29
| -33% | -$11.8K | ﹤0.01% | 3069 |
|
2014
Q4 | $24K | Buy |
88
+80
| +1,000% | +$21.8K | ﹤0.01% | 2861 |
|
2014
Q3 | $1K | Sell |
8
-197
| -96% | -$24.6K | ﹤0.01% | 3785 |
|
2014
Q2 | $50K | Buy |
205
+65
| +46% | +$15.9K | ﹤0.01% | 2041 |
|
2014
Q1 | $37K | Buy |
140
+13
| +10% | +$3.44K | ﹤0.01% | 2158 |
|
2013
Q4 | $46K | Sell |
127
-703
| -85% | -$255K | ﹤0.01% | 1967 |
|
2013
Q3 | $441K | Buy |
830
+47
| +6% | +$25K | 0.02% | 704 |
|
2013
Q2 | $183K | Buy |
+783
| New | +$183K | 0.01% | 1011 |
|